Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 15;24(18):4486-4491.
doi: 10.1016/j.bmc.2016.07.050. Epub 2016 Jul 25.

The development of peptide ligands that target helix 69 rRNA of bacterial ribosomes

Affiliations

The development of peptide ligands that target helix 69 rRNA of bacterial ribosomes

Danielle N Dremann et al. Bioorg Med Chem. .

Abstract

Antibiotic resistance prevents successful treatment of common bacterial infections, making it clear that new target locations and drugs are required to resolve this ongoing challenge. The bacterial ribosome is a common target for antibacterials due to its essential contribution to cell viability. The focus of this work is a region of the ribosome called helix 69 (H69), which was recently identified as a secondary target site for aminoglycoside antibiotics. H69 has key roles in essential ribosomal processes such as subunit association, ribosome recycling, and tRNA selection. Conserved across phylogeny, bacterial H69 also contains two pseudouridines and one 3-methylpseudouridine. Phage display revealed a heptameric peptide sequence that targeted H69. Using solid-phase synthesis, peptide variants with higher affinity and improved selectivity to modified H69 were generated. Electrospray ionization mass spectrometry was used to determine relative apparent dissociation constants of the RNA-peptide complexes.

Keywords: Helix 69; Ligand binding; Peptide; Pseudouridine; Ribosomal RNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A. The 70S E. coli bacterial ribosome (2AVY, 2AW4) is shown with H69 highlighted in cyan, aminoacyl-tRNA site (A site) in red, peptidyl transferase center (PTC) in purple, 30S subunit in light grey, and 50S subunit in yellow. B. Secondary structures of H69 are given (from left to right): human H69, wild-type H69 with E. coli numbering, modified H69 (ΨΨΨ), and unmodified H69 (UUU).
Figure 2
Figure 2
The base structures of uridine (left), pseudouridine (middle), and 3-methylpseudouridine (right) are shown.
Figure 3
Figure 3
The ESI mass spectrum shows RQVANHQ-NH2 (35 μM) bound to modified H69 (ΨΨΨ, 2.7 μM) RNA at a single titration point.
Figure 4
Figure 4
The titration curve for RQVANHQ-NH2 bound to ΨΨΨ is shown. The apparent dissociation constant (Kd) value is given.
Figure 5
Figure 5
The relative binding affinities and selectivities of the peptide variants for ΨΨΨ (upper) or UUU (lower) are illustrated. Each position contains either A, R, or the parent amino acid along with the remaining parent amino acid sequence, which is indicated in blue. The size of the letter indicates the relative affinity or selectivity of that amino acid variant compared to the other amino acids at that position, with larger letters indicating tighter binding or more selective species.

Similar articles

Cited by

References

    1. Florey HW. Acta Med Scand. 1947;128:495–504.
    1. Hermann T. Curr Opin Chem Biol. 2005;15:355–366. - PubMed
    1. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. Nature. 2000;407:340–348. - PubMed
    2. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. Science. 2000;289:905–920. - PubMed
    3. Davidovich C, Bashan A, Yonath A. Proc Natl Acad Sci USA. 2008;105:20665–20670. - PMC - PubMed
    4. Yusupov MM, Yusupova GZ, Baucom A, Lieberman K, Earnest TN, Cate JH, Noller HF. Science. 2001;292:883–896. - PubMed
    1. Bowen WS, Van Dyke N, Murgola EJ, Lodmell JS, Hill WE. J Biol Chem. 2005;280:2934–2943. - PubMed
    2. Rodriguez-Fonseca C, Phan H, Long KS, Porse BT, Kirillov SV, Amils R, Garrett RA. RNA. 2000;6:744–754. - PMC - PubMed
    3. Bulkley D, Johnson F, Steitz TA. J Mol Biol. 2012;416:571–578. - PMC - PubMed
    4. Wimberly BT, Brodersen DE, Clemons WM, Jr, Morgan-Warren RJ, Carter AP, Vonrhein C, Hartsch T, Ramakrishnan V. Nature. 2000;407:327–339. - PubMed
    5. Brodersen DE, Clemens WM, Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. Cell. 2000;103:1143–1154. - PubMed
    6. Borovinskaya MA, Shoji S, Holton JM, Fredrick K, Cate JH. ACS Chem Biol. 2007;2:545–552. - PMC - PubMed
    7. Alacaraz LA, del Alamo M, Barrera FN, Mateu MG, Neira JL. Biophys J. 2007;93:1264–1276. - PMC - PubMed
    1. Cannone JJ, Subramanian S, Schnare MN, Collett JR, D′Souza LM, Du Y, Feng B, Lin N, Madabusi LV, Müller KM, Pande N, Shang Z, Yu N, Gutell RR. BMC Bioinf. 2002;3:1–31. - PMC - PubMed

Publication types

LinkOut - more resources